Gov. Deval Patrick joined the Massachusetts Life Sciences Center and ARGO Medical Technologies at the AdvaMed 2012 conference in Boston on October 2, 2012, to announce that Israeli-founded exoskeleton technology leader, ARGO, has selected Massachusetts as its U.S. headquarters.
On October 1, 2012, independent medical device regulatory consulting firm Qserve Group announced that it has opened a new U.S. headquarters office for Qserve America, Inc., at the Cambridge Innovation Center in Cambridge, Mass.
On October 4, 2012, Sialix, Inc., a company developing products for the treatment and prevention of cancer and chronic inflammatory conditions, announced the execution of an option agreement with Momenta Pharmaceuticals to license an undisclosed monoclonal antibody therapeutic program under development by Sialix. In addition, Sialix announced that its corporate headquarters will be relocated to Cambridge, Mass., at Dogpatch Labs.
